https://www.selleckchem.com/pr....oducts/cobimetinib-g
Ophthalmic examinations of developmentally delayed/autistic children are challenging. Oral midazolam may be a viable alternative to general anaesthesia for this indication. Single-centre retrospective cohort study (January 2018-March 202. Oral midazolam (0.5 mg/kg, max 15 mg). Metrics included patient demographics, examination completion rate, duration of stay and adverse events. 50 oral midazolam examinations were performed (45 patients). Mean age was 79.12 months. All had developmental delay (66.67% autism). Time
Like
Comment
Share
